eFFECTOR Therapeutics (EFTR) Prices 7.76M Share Offering at $1.13/sh

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/15/2026

1. BAC
2. NVDA
3. DPZ
4. GS
5. ORCL
6. DRS
7. JPM
8. ACI
9. CRWV
10. UNH

Go back to eFFECTOR Therapeutics (EFTR) Prices 7.76M Share Offering at $1.13/sh

eFFECTOR Therapeutics Announces $8.7 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

June 7, 2023 8:00 AM EDT

SOLANA BEACH, Calif. and REDWOOD CITY, Calif., June 07, 2023 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer, today announced that it has entered into a definitive agreement with a single healthcare-focused institutional investor for the purchase and sale of an aggregate of 7,764,445 shares of its common stock (or common stock equivalents in lieu thereof), at a purchase price of $1.125 per share (or common stock equivalent in lieu thereof), in a registered direct offering priced at-the-market... More